Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

49.05 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,285
Open 49.05
Bid (Size) 48.52 (19)
Ask (Size) 48.69 (1)
Prev. Close 49.05
Today's Range 49.05 - 49.05
52wk Range 39.35 - 63.41
Shares Outstanding 2,222,113,553
Dividend Yield 4.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates. 
Via InvestorPlace
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
Investors should consider the long term prospects of the following three healthcare stocks as the U.S. population ages. 
Via InvestorPlace

Performance

YTD
-7.03%
-7.03%
1 Month
+18.77%
+18.77%
3 Month
+11.63%
+11.63%
6 Month
-0.69%
-0.69%
1 Year
-21.13%
-21.13%

More News

Read More
Post-it Manufacturer 3M Sticks Landing While Ford Tanks: Biggest Beats And Misses From Earnings Season So Far
Via Benzinga
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
Via Benzinga
Exposures COVID-19
Market Momentum: Your Weekly Financial Forecast
Via Benzinga
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Healthcare Stocks Are Coming On Strong In July Led By Biotech
Via Talk Markets
Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 Earnings
Via Benzinga
Pharma Giant's Shares Up After Impressive Q2 Earnings Release
Via MarketBeat
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Why I Loaded Up on This Ultra-High-Yielding ETF After the Nasdaq's Recent Slump
Via The Motley Fool
Topics ETFs
Dow Jumps Over 650 Points Following Inflation Data: Fear & Greed Index Moves To 'Neutral' Zone
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
2 High-Yield Dividend Stocks That Could Shine in 2025
Via The Motley Fool
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
Via Benzinga
Topics Economy
Exposures Economy
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
Via The Motley Fool
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Stocks To Watch Today: 3M, BMY, And Coursera Inc.
Via Talk Markets
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Exposures Fossil Fuels
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.